CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $14,892,000 | -17.1% | 600,000 | -40.0% | 0.11% | -15.2% |
| Q4 2018 | $17,960,000 | -68.6% | 1,000,000 | +63.9% | 0.13% | -77.7% |
| Q2 2017 | $57,114,000 | +1021.2% | 610,000 | +662.5% | 0.59% | +958.9% |
| Q1 2017 | $5,094,000 | -50.1% | 80,000 | -64.4% | 0.06% | -65.9% |
| Q3 2014 | $10,206,000 | +9.5% | 225,000 | 0.0% | 0.16% | +22.4% |
| Q2 2014 | $9,317,000 | – | 225,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |